The Hydralazine Hydrochloride Inject, cataloged under National Stock Number 6505-01-552-9488, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Novartis Pharmaceuticals Corporation. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-552-9488 |
| Primary Part Number | 102917 |
| Item Name | Hydralazine Hydrochloride Inject |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Novartis Pharmaceuticals Corporation |
| Status | ACTIVE |
| Administration | INTRAVENOUS INFUSION |
| Primary Container Content Quantity | 20.000 MILLIGRAMS |
| Primary Container Type | PACKET |
| Total Primary Container Quantity | 5 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| 544108 | Symbion Pharmacy Services (AUS) |
| 102917 PRIMARY | Novartis Pharmaceuticals Corporation (USA) |
| 9310312002762 | Gs1 Australia Pty Ltd (AUS) |
| 102917 | Novartis Pharmaceuticalsaust Pty Ltd (AUS) |
| Reference | Meaning |
|---|---|
| APRESOLINE AMP 5 X 1 ML | 5/9 Secondary reference Anspec Pty Ltd |
| 9310312002762 | 5/1 Secondary reference Anspec Pty Ltd |
NSN 6505-01-552-9488 is a Hydralazine Hydrochloride Inject, manufactured by Novartis Pharmaceuticals Corporation, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-552-9488 has 4 manufacturer part numbers on file: 544108 (Symbion Pharmacy Services), 102917 (Novartis Pharmaceuticals Corporation), 9310312002762 (Gs1 Australia Pty Ltd), 102917 (Novartis Pharmaceuticalsaust Pty Ltd).
Key specifications for 102917: Administration: INTRAVENOUS INFUSION; Primary Container Content Quantity: 20.000 MILLIGRAMS; Primary Container Type: PACKET; Part Name Assigned by Controlling Agency: HYDRALAZINE HYDROCHLORIDE. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.